Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous‐cell carcinoma of the esophagus
暂无分享,去创建一个
C. J. Lee | C. J. Chen | Yung‐Chie Lee | Jang-Ming Lee | Ming-Tsang Wu | J. M. Lee | Y. C. Lee | S. Y. Yang | W. Shi | S. Luh | C. Hsieh | M. Wu | Chun‐Jean Lee | Shi‐Yi Yang | Chien-Jen Chen | C. Hsieh | Wan‐Luen Shi | Shi‐Ping Luh
[1] C. Meijer,et al. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. , 2000, The Journal of general virology.
[2] A. Giannoudis,et al. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low‐ and high‐grade squamous intra‐epithelial lesions and invasive squamous carcinoma of the cervix , 1999, International journal of cancer.
[3] J. V. van Lanschot,et al. Barrett esophagus and cancer: pathogenesis, carcinogenesis, and diagnostic dilemmas. , 1999, Histology and histopathology.
[4] M. Spitz,et al. Glutathione‐S‐transferase polymorphisms and risk of squamous‐cell carcinoma of the head and neck , 1999, International journal of cancer.
[5] P. Dayer,et al. Glutathione S‐transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking‐related oral and pharyngeal cancers , 1999, International journal of cancer.
[6] C. J. Chen,et al. Ap53genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers , 1999, Hepatology.
[7] Miranda Thomas,et al. Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically , 1999, Molecular and Cellular Biology.
[8] T. Wobbes,et al. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. , 1999, Cancer research.
[9] A. Hirvonen. Polymorphic NATs and cancer predisposition. , 1999, IARC scientific publications.
[10] P. Lin,et al. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] Y. Doki,et al. Association between genetic polymorphisms of glutathione S‐transferase P1 and N‐acetyltransferase 2 and susceptibility to squamous‐cell carcinoma of the esophagus , 1998, International journal of cancer.
[12] I. Jacobs,et al. p53 codon 72 polymorphism and risk of cervical cancer in UK , 1998, The Lancet.
[13] Irene M. Leigh,et al. Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.
[14] G. B. Smith,et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.
[15] P. Dayer,et al. Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] S. Srivastava,et al. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. , 1997, Archives of biochemistry and biophysics.
[17] G. Prendergast,et al. The polyproline region of p53 is required to activate apoptosis but not growth arrest , 1997, Oncogene.
[18] A. Risch,et al. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. , 1997, Cytogenetics and cell genetics.
[19] L. Harries,et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.
[20] J. Buolamwini,et al. Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants , 1997, The Journal of Biological Chemistry.
[21] D. Forman,et al. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. , 1997, Carcinogenesis.
[22] S. Tsuchida,et al. Correlated Expression of Glutathione S‐Transferase‐π and c‐Jun or Other Oncogene Products in Human Squamous Cell Carcinomas of the Head and Neck: Relevance to Relapse after Radiation Therapy , 1997, Japanese journal of cancer research : Gann.
[23] J. Brockmöller,et al. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. , 1996, Cancer research.
[24] H. Vainio,et al. CARCINOGENESIS: Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas , 1996 .
[25] G. Hallmans,et al. p53 polymorphisms and haplotypes in breast cancer. , 1996, Carcinogenesis.
[26] M. Tagawa,et al. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. , 1996, Carcinogenesis.
[27] H. Vainio,et al. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. , 1996, Carcinogenesis.
[28] R. Benamouzig,et al. Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. , 1995, Gastroenterology.
[29] C. Smith,et al. Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk. , 1995, Clinical chemistry.
[30] Y. Ko,et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[31] M. Spitz,et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. , 1995, Carcinogenesis.
[32] N. Day,et al. Oesophageal cancer in never‐smokers and never‐drinkers , 1995, International journal of cancer.
[33] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[34] A. Rustgi,et al. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. , 1994, Gastroenterology.
[35] Jinfu Hu,et al. Risk factors for oesophageal cancer in northeast China , 1994, International journal of cancer.
[36] B. Mannervik,et al. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Syrjänen,et al. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization , 1993, Cancer.
[38] Jack A. Taylor,et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. , 1993, Carcinogenesis.
[39] T C Campbell,et al. Geographic association between urinary excretion of N‐nitroso compounds and oesophageal cancer mortality in china , 1993, International journal of cancer.
[40] K. Nakachi,et al. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. , 1993, Carcinogenesis.
[41] R. Rylander,et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population , 1993, FEBS letters.
[42] D. Hopwood,et al. Abnormal expression of growth regulatory factors in Barrett's oesophagus. , 1991, Clinical science.
[43] N. Day,et al. Risk factors for cancer of the oesophagus in Kerala, India , 1991, International journal of cancer.
[44] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[45] D. Grant,et al. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Kurosky,et al. Primary and secondary structural analyses of glutathione S-transferase π from human placenta , 1990 .
[47] K. Nakachi,et al. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene , 1990, FEBS letters.
[48] R. R. Smith,et al. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. , 1988, Human pathology.
[49] T. Mack,et al. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. , 1988, Cancer research.
[50] K. Ilett,et al. Acetylation phenotype in colorectal carcinoma. , 1987, Cancer research.
[51] D. Pim,et al. Primary structure polymorphism at amino acid residue 72 of human p53 , 1987, Molecular and cellular biology.
[52] D. Schottenfeld. Epidemiology of cancer of the esophagus. , 1984, Seminars in oncology.
[53] S. Lu,et al. Recent research on the etiology of esophageal cancer in China. , 1982, Zeitschrift fur Gastroenterologie.
[54] C. S. Yang,et al. Research on esophageal cancer in China: a review. , 1980, Cancer research.